According to the
Public Relations and International Affairs unit of the Medical Procurement
Organization, Soha Pharmaceutical Company continues to manufacture and distribute
products; tablets, capsules, syrups, and suspensions in compliance with GMP
standards and latest WHO regulations. In May of this year alone, nearly 11
million units of pharmaceuticals in different forms were produced and
introduced to the market.
Enhanced
collaboration among subsidiary companies towards synergistic growth is
increasingly on the agenda. A memorandum has been signed to strengthen supply
chains and sales between Soha Pharmaceutical Company, Helal Iran Medical
Devices Company, and the medications provided by Soha Kish Commercial Company.
With state-of-the-art
facilities in quality control laboratories and research and development, Soha
Pharmaceutical Company aims to continually expand its product range. The
pharmaceutical research division endeavors to add new products in the fields of
supplements, natural products, and traditional remedies. Progress has been made
in developing new products in herbal, gastrointestinal, urological, pain relief,
and anti-diabetic categories, with updates to follow in due course.